Santen Pharmaceutical Co., Ltd. GAAP EPS of ¥66.05, revenue of ¥210.76B
Source: SeekingAlpha
2026-02-05 10:33:02 ET
More on Santen Pharmaceutical Co., Ltd.
- Seeking Alpha’s Quant Rating on Santen Pharmaceutical Co., Ltd.
- Historical earnings data for Santen Pharmaceutical Co., Ltd.
- Dividend scorecard for Santen Pharmaceutical Co., Ltd.
- Financial information for Santen Pharmaceutical Co., Ltd.
Read the full article on Seeking Alpha
For further details see:
Santen Pharmaceutical Co., Ltd. GAAP EPS of ¥66.05, revenue of ¥210.76B
Santen Pharmaceutical Co. Ltd. ADR
NASDAQ: SNPHY
SNPHY Trading
0.0% G/L:
$10.665 Last:
158 Volume:
$10.665 Open:
